Furthermore, our results demonstrated that serum IL-40 levels in MG patients significantly decreased following immunosuppressive treatment (24.08 ± 16.75 vs. 13.84 ± 9.54 pg/mL, p < 0.0001) (Figure 2A). The gene discussed is C17orf99; the disease is myasthenia gravis.